Immunotherapy for Metastatic Solid Cancers

The overwhelming majority of metastatic solid cancers cannot be cured by current systemic chemotherapies. Immunotherapy, a modality able to mediate durable and sometimes complete tumor regression in patients with metastatic melanoma and kidney cancer, is emerging as an alternative or an adjunct to current cancer treatments. Recent developments have enabled the application of immunotherapy to additional cancer types.